Zobrazeno 1 - 10
of 334
pro vyhledávání: '"Soo Taek Uh"'
Autor:
Jieun Kang, Man Pyo Chung, Moo Suk Park, In Jae Oh, Heung Bum Lee, Young Whan Kim, Jong Sun Park, Soo Taek Uh, Yun Seong Kim, Yangjin Jegal, Jin Woo Song
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Background: Pirfenidone, an antifibrotic medication approved for the treatment of idiopathic pulmonary fibrosis (IPF), often requires dose reduction owing to adverse events. In this study, we evaluated if pirfenidone’s reduced dose has any impact o
Externí odkaz:
https://doaj.org/article/092027fd58ed440693a89e8553d5c488
Autor:
Sang Hoon Lee, Moo Suk Park, Song Yee Kim, Dong Soon Kim, Young Whan Kim, Man Pyo Chung, Soo Taek Uh, Choon Sik Park, Sung Woo Park, Sung Hwan Jeong, Yong Bum Park, Hong Lyeol Lee, Jong Wook Shin, Eun Joo Lee, Jin Hwa Lee, Yangin Jegal, Hyun Kyung Lee, Yong Hyun Kim, Jin Woo Song, Jong Sun Park
Publikováno v:
Respiratory Research, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background The effects of corticosteroid-based therapy in patients with idiopathic nonspecific interstitial pneumonia (iNSIP), and factors affecting treatment outcome, are not fully understood. We aimed to investigate the long-term treatment
Externí odkaz:
https://doaj.org/article/bd8bffc0ccef4b4fb9eb6d0b02ca2549
Autor:
Ji An Hwang, Joo Han Song, Jung Hoon Kim, Man Pyo Chung, Dong Soon Kim, Jin Woo Song, Young Whan Kim, Sun Mi Choi, Seung Ick Cha, Soo Taek Uh, Choon-Sik Park, Sung Hwan Jeong, Yong Bum Park, Hong Lyeol Lee, Jong Wook Shin, Eun Joo Lee, Yangjin Jegal, Hyun Kyung Lee, Jong Sun Park, Moo Suk Park
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background This study aimed to investigate clinical characteristics of Korean PAP patients and to examine the potential risk factors of PAP. Methods We retrospectively reviewed medical records of 78 Korean PAP patients diagnosed between 1993
Externí odkaz:
https://doaj.org/article/048ed6816ba94cd9b17659e0391063a1
Autor:
Joonyong Jang, So-My Koo, Ki-Up Kim, Yang-Ki Kim, Soo-taek Uh, Gae-Eil Jang, Wonho Chang, Bo Young Lee
Publikováno v:
Tuberculosis and Respiratory Diseases. 85:249-255
Background: The main cause of death in pulmonary embolism (PE) is right-heart failure due to acute pressure overload. In this sense, extracorporeal membrane oxygenation (ECMO) might be useful in maintaining hemodynamic stability and improving organ p
Autor:
Yangjin, Jegal, Jong Sun, Park, Song Yee, Kim, Hongseok, Yoo, Sung Hwan, Jeong, Jin Woo, Song, Jae Ha, Lee, Hong Lyeol, Lee, Sun Mi, Choi, Young Whan, Kim, Yong Hyun, Kim, Hye Sook, Choi, Jongmin, Lee, Soo-Taek, Uh, Tae-Hyung, Kim, Sang-Heon, Kim, Won-Yeon, Lee, Yee Hyung, Kim, Hyun-Kyung, Lee, Eun Joo, Lee, Eun Young, Heo, Sei Hoon, Yang, Hyung Koo, Kang, Man Pyo, Chung
Publikováno v:
Tuberculosis and Respiratory Diseases. 85:185-194
Background: The Korea Interstitial Lung Disease Study Group has made a new nationwide idiopathic pulmonary fibrosis (IPF) registry because the routine clinical practice has changed due to new guidelines and newly developed antifibrotic agents in the
Autor:
Jae Ha Lee, Ji Hoon Jang, Hang-Jea Jang, Song Yee Kim, Man Pyo Chung, Hongseok Yoo, Sung Hwan Jeong, Jin Woo Song, Hong Lyeol Lee, Sun Mi Choi, Young Whan Kim, Yong Hyun Kim, Sung Woo Park, Jong Sun Park, Yangin Jegal, Jongmin Lee, Soo-Taek Uh, Tae-Hyung Kim, Yee Hyung Kim, Beomsu Shin, Hyun-kyung Lee, Sei-Hoon Yang, Hyun Lee, Sang-Heon Kim, Eun-Joo Lee, Hye Sook Choi, Hyung Koo Kang, Eun Young Heo, Won-Yeon Lee, Moo Suk Park
Publikováno v:
Frontiers in Medicine. 10
BackgroundIdiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD) with variable and heterogeneous clinical course. The GAP (gender, age, and physiology) model had been used to predict mortality in patients with
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are tolerable drugs used for patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC). Serious adverse reactions are uncommon compared with cytotoxic drug
Autor:
Hee-Young Yoon, Soo-Taek Uh
Publikováno v:
Tuberculosis and respiratory diseases. 85(4)
Coronavirus disease 2019 (COVID-19) has become a major health burden worldwide, with over 450 million confirmed cases and 6 million deaths. Although the acute phase of COVID-19 management has been established, there is still a long way to go to evalu
Autor:
Jongsun Park, Yun Seong Kim, Jin Woo Song, Man Pyo Chung, Soo Taek Uh, Yangjin Jegal, Moo Suk Park, Young Whan Kim, In-Jae Oh, Heung Bum Lee
Publikováno v:
Advances in Therapy
Aim The efficacy and safety of pirfenidone have been previously demonstrated in patients with mild-to-moderate idiopathic pulmonary fibrosis (IPF). However, the effect of pirfenidone in patients with advanced IPF remains unclear. Here, we investigate
Autor:
Sang Hoon Lee, M.D., Yoomi Yeo, M.D., Tae-Hyung Kim, M.D., Ph.D., Hong Lyeol Lee, M.D., Ph.D., Jin Hwa Lee, M.D., Ph.D., Yong Bum Park, M.D., Jong Sun Park, M.D., Ph.D., Yee Hyung Kim, M.D., Ph.D., Jin Woo Song, M.D., Ph.D., Byung Woo Jhun, M.D., Ph.D., Hyun Jung Kim, M.D., Ph.D., Jinkyeong Park, M.D., Ph.D., Soo-Taek Uh, M.D., Ph.D., Young Whan Kim, M.D., Ph.D., Dong Soon Kim, M.D., Ph.D., Moo Suk Park, M.D., Ph.D., on behalf of Korean Interstitial Lung Diseases Study Group
Publikováno v:
Tuberculosis and Respiratory Diseases, Vol 82, Iss 2, Pp 102-117 (2019)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases a